Bayesian reanalysis of the PROfound trial: Olaparib in Asian patients with metastatic castration-resistant prostate cancer

Asian Journal of Urology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles